(Q48412498)

11 February 2018

title

Lithium and bupropion antagonise the phasic changes in locomotor activity caused by dopamine infused into the rat nucleus accumbens. (English)

1 reference

11 February 2018

1 reference

J C Barnes

1

1 reference

11 February 2018

B Costall

series ordinal

2

1 reference

11 February 2018

A M Domeney

series ordinal

3

1 reference

11 February 2018

R J Naylor

series ordinal

4

1 reference

11 February 2018

publication date

1 January 1986

1 reference

11 February 2018

published in

Psychopharmacology

1 reference

11 February 2018

volume

89

1 reference

11 February 2018

issue

3

1 reference

11 February 2018

page(s)

311-316

1 reference

11 February 2018

https://scigraph.springernature.com/pub.10.1007/bf00174366

exact match

0 references

cites work

Long-Term Treatment with Lithium Prevents the Development of Dopamine Receptor Supersensitivity

1 reference

12 December 2020

Long-term consequences of antagonism by neuroleptics of behavioural events occurring during mesolimbic dopamine infusion

1 reference

12 December 2020

The continuity of dopamine receptor antagonism can dictate the long-term behavioural consequences of a mesolimbic infusion of dopamine.

1 reference

12 December 2020

Lithium effects on haloperidol-induced pre- and postsynaptic dopamine receptor supersensitivity

1 reference

12 December 2020

Behavioural and biochemical consequences of persistent overstimulation of mesolimbic dopamine systems in the rat.

1 reference

12 December 2020

Psychopharmacological implications of dopamine and dopamine antagonists: a critical evaluation of current evidence

1 reference

12 December 2020

Lithium, manic-depression, and the chemistry of the brain.

1 reference

12 December 2020

The effect of lithium on an animal model of tardive dyskinesia

1 reference

12 December 2020

Bupropion's prophylactic efficacy in bipolar affective illness

1 reference

12 December 2020

Characterization of the bupropion cue in the rat: lack of evidence for a dopaminergic mechanism.

1 reference

12 December 2020

Possible receptor effects of chronic lithium administration

1 reference

12 December 2020

Combining lithium and antidepressants

1 reference

12 December 2020

The effects of chronic lithium on behavioral and biochemical indices of dopamine receptor supersensitivity in the rat

1 reference

12 December 2020

Bupropion: a new antidepressant drug, the mechanism of action of which is not associated with down-regulation of postsynaptic beta-adrenergic, serotonergic (5-HT2), alpha 2-adrenergic, imipramine and dopaminergic receptors in brain.

1 reference

12 December 2020

Chlorimipramine, electroconvulsive shock and combination thereof: differential effects of chronic treatment on apomorphine-induced behaviours and on striatal and mesocortical dopamine turnover.

1 reference

12 December 2020

Repeated treatment with imipramine potentiates the locomotor effect of apomorphine administered into the hippocampus in rats

1 reference

12 December 2020

Denervation in the dopaminergic mesolimbic system: functional changes followed using (-)N-n-propylnorapomorphine depend on the basal activity levels of rats

1 reference

12 December 2020

Haloperidol-induced presynaptic dopamine supersensitivity is blocked by chronic lithium

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00174366

1 reference

11 February 2018

PubMed ID

3088656

1 reference

11 February 2018